Healthcare Services

Lupus Nephritis Market to Reach $2.98 Billion by 2030 at 7.4% CAGR

April 23, 2026April 26, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Does The Market Size Of The Lupus Nephritis Market Compare Between 2026 And 2030?

The lupus nephritis market has experienced substantial growth in recent years. It is projected to expand from $2.08 billion in 2025 to $2.24 billion in 2026, achieving a compound annual growth rate (CAGR) of 7.7%. The market’s historical growth was fueled by the increasing prevalence of systemic lupus erythematosus, refined kidney biopsy and diagnostic techniques, the broad application of corticosteroids in treatment, expanding hospital-based nephrology care, and elevated awareness of autoimmune kidney diseases.

The lupus nephritis market size is projected to experience substantial expansion in the coming years, forecast to reach $2.98 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.4%. This anticipated growth during the forecast period is attributed to factors such as rising investment in biologic drug development, an increasing focus on early intervention to prevent kidney failure, the growing adoption of combination therapy regimens, the expansion of specialty nephrology clinics, and increasing healthcare spending on autoimmune disease management. Major trends expected in this period include a heightened focus on early diagnosis and disease monitoring, the growing uptake of immunosuppressive and biologic therapies, an increasing emphasis on personalized treatment approaches, the expansion of long-term disease management strategies, and rising awareness of autoimmune kidney complications.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=22044&type=smp

What Significant Factors Are Influencing The Lupus Nephritis Market Expansion?

The expanding presence of genetic susceptibility is anticipated to drive the future expansion of the lupus nephritis market. Genetic predisposition denotes inherited genetic characteristics in an individual that elevate their risk of developing specific illnesses or health conditions. The rising occurrence of genetic predisposition stems from elements like inheritance, environmental factors, and alterations in particular genes. This growing prevalence of genetic predisposition significantly contributes to the onset of lupus nephritis, highlighting the influence of inherited genetic elements in autoimmune conditions, especially those impacting kidney function. As an illustration, the Cystic Fibrosis Trust, a national charity in the UK, reported in October 2024 that the UK CF Registry had 11,148 registered patients in 2022, a figure that climbed to 11,318 by 2024, indicating a 1.52% rise in individuals affected by cystic fibrosis (CF). Consequently, the escalating prevalence of genetic predisposition is fueling the expansion of the lupus nephritis market.

How Is The Lupus Nephritis Market Organized By Segment Classification?

The lupus nephritis market covered in this report is segmented –

1) By Stage: Class 1, Class 2, Class 3, Other Stages

2) By Drug Class: Immunosuppressive Drugs, Corticosteroids, Biological Agents, Antimalarial Drugs

3) By Route Of Administration: Oral, Parenteral, Other Routes Of Administration

4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy

5) By End-User: Hospitals, Specialty Clinics, Other End-Users

Subsegments:

1) By Class 1: Asymptomatic Cases, Mild Proteinuria, Incidental Diagnosis

2) By Class 2: Mild Hematuria, Low-Grade Proteinuria, Minimal Immune Complex Deposition

3) By Class 3: Active Lesions, Chronic Sclerotic Lesions, Crescent Formation

4) By Other Stages: Class 4 (Diffuse Lupus Nephritis), Class 5 (Membranous Lupus Nephritis), Class 6 (Advanced Sclerotic Lupus Nephritis)

What Trends Are Affecting The Direction Of The Lupus Nephritis Market?

Prominent companies within the lupus nephritis market are concentrating on advancing second-generation calcineurin inhibitors, seeking to elevate treatment effectiveness and foster better long-term kidney outcomes for individuals. These second-generation calcineurin inhibitors are utilized in lupus nephritis to mitigate inflammation and avert renal damage by moderating immune responses. For example, in September 2024, Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical firm based in Canada, declared that the Japanese Ministry of Health, Labour, and Welfare had granted approval for LUPKYNIS (voclosporin) in the treatment of lupus nephritis. This authorization permits voclosporin’s application alongside mycophenolate mofetil (MMF), supported by information from the AURORA Clinical Program, which evidenced its safety and efficacy. The approval constitutes a vital landmark in broadening the range of treatment alternatives for lupus nephritis patients in Japan, thereby improving disease oversight and patient results.

Who Are The Industry Participants Involved In The Lupus Nephritis Market?

Major companies operating in the lupus nephritis market are F Hoffmann La Roche Ltd, Bristol Myers Squibb, Novartis AG, GlaxoSmithKline plc, Eli Lilly and Company, AstraZeneca PLC, Pfizer Inc, Johnson and Johnson, Merck and Co Inc, Sanofi, AbbVie Inc, Bayer AG, Amgen Inc, UCB SA, Otsuka Pharmaceutical Co Ltd, Aurinia Pharmaceuticals Inc, RemeGen Co Ltd, Kezar Life Sciences, Equillium Inc, Kyverna Therapeutics Inc, Biogen Inc

Get The Full Lupus Nephritis Market Report:

https://www.thebusinessresearchcompany.com/report/lupus-nephritis-global-market-report

Which Region Is The Leading Market For The Lupus Nephritis Market?

Asia-Pacific was the largest region in the lupus nephritis market in 2025. The regions covered in the lupus nephritis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Lupus Nephritis Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/lupus-nephritis-global-market-report

Browse Through More Reports Similar to the Global Lupus Nephritis Market 2026, By The Business Research Company

Cutaneous Lupus Erythematosus Market Report 2026

https://www.thebusinessresearchcompany.com/report/cutaneous-lupus-erythematosus-global-market-report

Lupus Therapeutics Market Report

https://www.thebusinessresearchcompany.com/report/lupus-therapeutics-global-market-report

Kidney Disease Market Report

https://www.thebusinessresearchcompany.com/report/kidney-disease-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795